CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1613.905.55 (+0.35 %)
PREV CLOSE () 1608.35
OPEN PRICE () 1607.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 15033
TODAY'S LOW / HIGH ()1598.75 1636.10
52 WK LOW / HIGH ()655.75 1703.8
NSE1611.452.35 (+0.15 %)
PREV CLOSE() 1609.10
OPEN PRICE () 1606.00
BID PRICE (QTY) 1611.45 (65)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 762738
TODAY'S LOW / HIGH() 1600.10 1636.95
52 WK LOW / HIGH ()655.4 1704.25
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Apr Lupin informs about stop transfer
Lupin has informed that it enclosed the details of share certificate, re..
12Apr USFDA completes GMP inspection at Lupi
United States Food and Drug Administration (USFDA) has completed a GMP I..
12Apr Lupin informs about press release
Lupin has informed that it enclosed a Press Release as regards, the succ..
10Apr Lupin recalls 26,352 bottles of Rifamp
Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an anti..
10Apr Lupin launches first generic version o
Lupin has launched first generic version of Oracea (Doxycycline Capsules..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit9164.399999999994252.10000000001
Gross Profit 10839.6 5271.40000000001
Operating Profit 1240511739.2
Net Sales 41157.5112588.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 7494.65 (5.48%)
M.Cap ( in Cr)
9615.55
NGL Fine-Chem (BSE)
 2238.00 (4.74%)
M.Cap ( in Cr)
1382.64
Astrazeneca Pharma I (BSE)
 5282.15 (1.73%)
M.Cap ( in Cr)
13205.38
SMS Lifesciences (BSE)
 729.35 (6.09%)
M.Cap ( in Cr)
220.50
Divi's Lab (BSE)
 3755.15 (1.07%)
M.Cap ( in Cr)
99687.43
Shareholding Pattern
PROMOTERS 47.01%
MUTUAL FUNDS/UTI 16.82%
FI/BANKS/INSURANCE 10.02%
NON-INSTITUTION 6.93%
GOVERNMENT 0.01%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX72943.68-456.10 (-0.62%)
NIFTY22147.90-124.60 (-0.56%)
Dow Jones 37735.11-248.13 (-0.65%)
Nasdaq 15885.02-290.07 (-1.79%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI